The Goal of NAD+ Therapy and Tools We Use
Sterility Confirmation Ensures the product is free from contaminants, including bacteria and pathogens, in accordance with guidelines
Post-protocol maintenance After completing an initial protocol, some researchers use lower-frequency maintenance dosing (BPC-157 once daily or every other day, TB-500 once weekly) for an additional 4 to 6 weeks
Insurance coverage for therapeutic peptides remains limited, as most insurers classify them as experimental or investigational treatments
Recalls & Warnings May 24, 2013 Maker of Neuropathic Pain Product Warned For Drug Claims, Misbranding On April 11, 2013, the FDA issued a warning letter to Realm Labs, LLC, following a review of the companys websites which found statements made about its NeuRemedy products to be drug claims
U.S.-based fulfillment center Pharmaceutical-grade supply Clinical resources and educational blogs Transparent customer service Learn more about us: Visit BacteriostaticWaterUSA.com